We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Arana Therap. | LSE:AAHX | London | Ordinary Share | AU000000AAH8 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:0691I
Arana Therapeutics Limited
20 November 2007
For Immediate Release 20 November 2007
ARANA THERAPEUTICS LTD
DIRECTOR'S SHARE PURCHASE
Arana Therapeutics Ltd, (LSE: AAHx ASX: AAH) ("Arana" or the "Company"), the
Australian biopharmaceutical company, formed through the merger of Peptech and
EvoGenix in August 2007. The Company uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer. The Company has received notification on 16 November 2007
that the following Director purchased ordinary fully paid shares in the capital
of the Company. Details are as follows:
Director Direct or No. of Date Price per Total Subsequent
Indirect Ordinary Purchased Share (A$) Consideration beneficial
Interest Shares (A$) holding
purchased
Greg Direct 50,000 15 1.185 59,250 300,000
Bundy November
2007
For further information, please contact:
Arana Therapeutics Ltd
Dr John Chiplin, Chief Executive Officer +61 (0)2 9870 8788
Niall Henderson, Chief Financial Officer +61 (0)2 9870 8788
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) +44 (0)20 7466 5000
Rebecca Skye Dietrich / Catherine Breen
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSOKKKQFBDKNDB
1 Year Arana Therap. Chart |
1 Month Arana Therap. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
